Candida auris has been confirmed in 23 states since its first U.S. report in 2016, with concentrations exceeding 700 cases in Texas and 503 in Michigan as of mid-July. The fungus resists standard antifungal drugs, persists on surfaces, and transmits via medical devices in hospital settings, while healthy individuals typically clear it without intervention. Available reporting draws from two sources representing a single bias category.